Literature DB >> 29365381

[Application of virtual reality in surgical treatment of complex head and neck carcinoma].

Y Q Zhou1, C Li2, C Y Shui3, Y C Cai2, R H Sun2, D F Zeng2, W Wang2, Q L Li3, L Huang1, J Tu2, J Jiang2.   

Abstract

Objective: To investigate the application of virtual reality technology in the preoperative evaluation of complex head and neck carcinoma and he value of virtual reality technology in surgical treatment of head and neck carcinoma.
Methods: The image data of eight patients with complex head and neck carcinoma treated from December 2016 to May 2017 was acquired. The data were put into virtual reality system to built the three-dimensional anatomical model of carcinoma and to created the surgical scene. The process of surgery was stimulated by recognizing the relationship between tumor and surrounding important structures. Finally all patients were treated with surgery. And two typical cases were reported.
Results: With the help of virtual reality, surgeons could adequately assess the condition of carcinoma and the security of operation and ensured the safety of operations. Conclusions: Virtual reality can provide the surgeons with the sensory experience in virtual surgery scenes and achieve the man-computer cooperation and stereoscopic assessment, which will ensure the safety of surgery. Virtual reality has a huge impact on guiding the traditional surgical procedure of head and neck carcinoma.

Entities:  

Keywords:  Head and neck neoplasms; Surgical procedures, operative; Virtual reality technology

Mesh:

Year:  2018        PMID: 29365381     DOI: 10.3760/cma.j.issn.1673-0860.2018.01.011

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  1 in total

1.  Digital surgery group versus traditional experience group in head and neck reconstruction: a retrospective controlled study to analyze clinical value and time-economic-social effect.

Authors:  Ronghao Sun; Yuqiu Zhou; Michelle Z Malouta; Yongcong Cai; Chunyan Shui; Li Zhu; Xu Wang; Jingqiang Zhu; Chao Li
Journal:  World J Surg Oncol       Date:  2022-06-30       Impact factor: 3.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.